| Company/Division name | Novartis |
| Parent company | Novartis |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Total number of jobs (added or to be added): | 100 |
| Year reshoring announced: | 2024 |
| Year reshoring implemented or to be implemented: | 2024 |
| Country(ies) from which reshored: | Switzerland |
| City reshored to: | Indianapolis |
| State(s) reshored to: | IN |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | cancer treatment, radioligand therapy |
| What domestic positive factors made reshoring more attractive? | Impact on domestic economy, Proximity to customers/market |
